XtalPi Showcases AI-Powered Robotics and Integrated Analytical Platforms at China Pharmaceutical Industry Development Conference

Nov 18, 2024 19:10 CST Updated 19:10

XtalPi

Computation-Driven Innovative Drug R&D Provider

On November 16, the 2024 China Pharmaceutical Industry Development Conference and Shanghai International Biomedical Industry Week opened at the Zhangjiang Science Hall in Shanghai.XtalPi's AI Robotic Lab Cluster Recognized as a Typical Case of Global Cooperation in the Pharmaceutical Industry; Its Self-Designed and Developed Integrated Chemical Synthesis, Testing, and Analysis Machine Featured in the Industry Development Innovation Achievements Exhibition.

On the opening day, Chen Jining, Secretary of the Shanghai Municipal Committee; Jin Zhuanglong, Minister of Industry and Information Technology; Zeng Yixin, Vice Minister of the National Health Commission; Gong Zheng, Deputy Secretary of the Shanghai Municipal Committee and Mayor of Shanghai; Zhu Zhisong, Member of the Standing Committee of the Shanghai Municipal Committee and Secretary of the Pudong New Area Committee, and other key participating leaders watched the live demonstration of the AI robotic experimental workstation. They also heard a report from XtalPi on the company's commitment to independent innovation, utilizing core technologies such as artificial intelligence, quantum physics, and robotics to reduce costs, improve efficiency, and enhance the accessibility of innovative drugs in the drug research and development process. The leaders encouraged the company to remain focused on scientific and technological innovation and to develop new productive forces.

During the conference, XtalPi, as a representative of China's biopharmaceutical innovation enterprises, was invited to participate in the symposium on high-quality development of the pharmaceutical industry, where entrepreneurs from central state-owned enterprises and global multinational pharmaceutical companies gathered to discuss a new era of high-quality development for China's pharmaceutical industry.

November 18,Dr. Lipo Lai, Co-founder and Chief Innovation Officer of XtalPiInvited to deliver a keynote speech at the Biomedical Digital Intelligence Innovation and Development Forum of the conference, discussing with experts from academia, industry, research, and application fields, including Tang Peifu, an academician of the Chinese Academy of Engineering, Huang Tiejun, chairman of the Beijing Academy of Artificial Intelligence, as well as representatives from the China Academy of Information and Communications Technology, Janssen Innovative Pharmaceuticals, and MSD, on the new developments in the biomedical industry empowered by digital intelligence technologies. Sharing the XtalPi model of cutting-edge technologies like artificial intelligence in the field of innovative drug R&D.

China's Role in Global Pharmaceutical Industry Development: From Participant to DriverChina has transformed from a participant to a driver in the global pharmaceutical industry, continuously contributing Chinese wisdom and solutions to the development of global healthcare. China is expected to lead the global pharmaceutical industry into a more efficient, precise, and sustainable new era. XtalPi always regards technological innovation as its mission, constantly increasing R&D investment. It drives innovation through artificial intelligence, quantum physics, and robotics, promoting a paradigm shift in scientific research and accelerating the development of AI-driven drug discovery and new materials. The company also strengthens open collaboration, deeply integrating into the global innovation and industrial chains, promoting the deep integration of technological and industrial innovation, and contributing to human health and global green sustainable development.